Home > Press > Lumera Corporation Announces Order from Fujitsu Labs of America
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, today announced a purchase order from Fujitsu Laboratories of America (FLA), at http://www.fla.fujitsu.com , for its electro-optic polymer modulators.
Lumera Corporation Announces Order from Fujitsu Labs of America
BOTHELL, WA | Posted on May 23rd, 2007
"We have been working with FLA in the field of optical interconnects, creating polymer modulator arrays that can work at data rates of 10 Gbps," said Dr. Raluca Dinu, Director of Lumera's Electro-Optic Business Unit. "We look forward to an ongoing relationship with them as they continue to develop innovative circuit board solutions."
FLA is performing research activity in the areas of optical interconnect development. In testing polymer optical modulators FLA found Lumera's electro-optical polymer modulators offered high data rate connections. Fujitsu Limited has patent applications for a module or subsystem using a polymer modulator in such module or subsystem.
About Lumera Corporation
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit http://www.lumera.com .
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
For more information, please click here
Hélène F. Jaillet, 425-398-6546
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
Industrial Nanotech, Inc. Announces New OEM Customer January 27th, 2015
DELMIC reports on applications of their SPARC technology at the Chalmers University of Technology in Gothenburg, Sweden December 16th, 2014
Industrial Nanotech, Inc. Expands Government and Defense Projects December 10th, 2014
Iran Exports Nanodrugs to Syria November 24th, 2014